Johnson & Johnson (JNJ) Tops Q1 EPS by 25c, Updates Guidance

(Updated - April 20, 2021 6:36 AM EDT)

Johnson & Johnson (NYSE: JNJ) reported Q1 EPS of $2.59, $0.25 better than the analyst estimate of $2.34. Revenue for the quarter came in at $22.32 billion versus the consensus estimate of $22.01 billion.

GUIDANCE:

Johnson & Johnson sees FY2021 EPS of $9.42-$9.57, versus the consensus of $9.50. Johnson & Johnson sees FY2021 revenue of $90.6-9.1.6 billion, versus the consensus of $92.2 billion.

For earnings history and earnings-related data on Johnson & Johnson (JNJ) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Pfizer lung cancer drug misses survival goal in Phase 3 trial
• JPMorgan Starts ICICI Prudential Asset Management (ICICIAMC:IN) at Overweight